ADVANZ PHARMA acquires Testoviron® rights from Bayer in Europe and parts of LATAM, MEA, and APAC
Thursday, June 19, 2025
ADVANZ PHARMA Holdco Limited, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines across Europe, Canada, and Australia, has completed the purchase of the commercial rights to Testoviron® from Bayer for Europe and selected markets in Latin America, the Middle East & Africa, and Asia-Pacific.
Testoviron® is a long-acting injectable testosterone used to treat male hypogonadism*. Adding the brand strengthens ADVANZ PHARMA’s specialty portfolio and leverages its commercial and medical operations in Europe and global partner network.
The transaction builds on existing agreements between ADVANZ PHARMA and Bayer. Financial terms are not being disclosed.
*Indications vary by market, strength, and form. For local indications please check the local approved label
About ADVANZ PHARMA
Partner of choice in specialty, hospital, and rare disease medicines
ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing and enhancing the specialty, hospital, and rare disease medicines they depend on. Our headquarters are in London, UK. We have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia, a Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network. ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, biosimilars & specialty generics, and originator brands. Our products cover a broad range of therapeutic areas, including hepatology, rheumatology, gastroenterology, anti-infectives, critical care, endocrinology, oncology, CNS, and, more broadly, rare disease medicines. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with biopharma and development companies to bring medicines to patients. We can only achieve this due to our dedicated and highly qualified employees, acting in line with our company values of entrepreneurship, speed, and integrity.
For more information, please visit our Website or LinkedIn.
For media inquiries, please contact:
Courtney Baines
ADVANZ PHARMA
Tel: +44 7776 516979 Email: courtney.baines@advanzpharma.com
Source: advanzpharma.com
